Skip to content

Vericel Corp

VCEL· NasdaqCore metricsCIK 887359

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -3.54%
Market cap
$2.93B
51.03M shares
Filings
1,042
$85.37M
Q3 2026+16.5% FY25 yoy
$14.16M
Q3 2026+59.4% FY25 yoy
$12.19M
Q3 2026+144.4% FY25 yoy
$45.07M
Q3 2026derivedN/M FY25 yoy
$0.27
Q3 2026+60.0% FY25 yoy
$133.49M
Q3 2026+34.3% FY25 yoy
$2.93B
87.9×
9.0×
7.6×
1.98%
—

Twelve months to Sep 30, 2026 · derived

Price

$57.37+39.76%+$16.32past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$276.26MFY 2025
$276.26M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$276,259,000reported
FY 20242024-12-31$237,224,000reported
FY 20232023-12-31$197,516,000reported
FY 20222022-12-31$163,698,000reported
FY 20212021-12-31$153,075,000reported
FY 20202020-12-31$121,968,000reported
FY 20192019-12-31$117,850,000reported
FY 20182018-12-31$90,857,000reported
FY 20172017-12-31$62,760,000 revisedreported
FY 20162016-12-31$54,383,000reported
FY 20152015-12-31$51,168,000reported
FY 20142014-12-31$28,796,000reported

Biological products, except diagnostic substances

Vericel Corp is the 20th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Vericel Corp · CIK 887359 · Engraved from SEC EDGAR